Prevalence of steatotic liver disease (MASLD, MetALD, ALD) and clinically significant fibrosis in US adolescents

Prevalence of steatotic liver disease (MASLD, MetALD, ALD) and clinically significant fibrosis in US adolescents

Abstract We aim to evaluate the prevalence of steatotic liver disease (SLD) in United States (US) adolescents and explore whether metabolic dysfunction-associated steatotic liver disease (MASLD) can identify individuals with clinically significant fibrosis (CSF) in this study. The prevalence of SLD...

Full description

Bibliographic Details
Main Authors: Guang-Xia Shi, Yun-Song Qian, Chun-Mei Jiang, Zhen-Zhen Liu, Xi Yang, Yi-Wen Xu, Su-Su Jin, Jin-Guo Chu, Guo-Qing Qian, Nai-Bin Yang
Format: Article
Language:English
Published: Nature Portfolio 2024-10-01
Series:Scientific Reports
Subjects:
SLD
MASLD
Fibrosis
Adolescent
Online Access:https://doi.org/10.1038/s41598-024-76922-9

Internet

https://doi.org/10.1038/s41598-024-76922-9

Similar Items